495 related articles for article (PubMed ID: 24283197)
1. Unexpected abrupt increase in left ventricular assist device thrombosis.
Starling RC; Moazami N; Silvestry SC; Ewald G; Rogers JG; Milano CA; Rame JE; Acker MA; Blackstone EH; Ehrlinger J; Thuita L; Mountis MM; Soltesz EG; Lytle BW; Smedira NG
N Engl J Med; 2014 Jan; 370(1):33-40. PubMed ID: 24283197
[TBL] [Abstract][Full Text] [Related]
2. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
[TBL] [Abstract][Full Text] [Related]
3. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.
Uriel N; Han J; Morrison KA; Nahumi N; Yuzefpolskaya M; Garan AR; Duong J; Colombo PC; Takayama H; Thomas S; Naka Y; Jorde UP
J Heart Lung Transplant; 2014 Jan; 33(1):51-9. PubMed ID: 24290832
[TBL] [Abstract][Full Text] [Related]
4. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
[TBL] [Abstract][Full Text] [Related]
5. Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.
Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
Artif Organs; 2013 Jul; 37(7):606-14. PubMed ID: 23692322
[TBL] [Abstract][Full Text] [Related]
6. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
7. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
[TBL] [Abstract][Full Text] [Related]
8. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
9. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
[TBL] [Abstract][Full Text] [Related]
10. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
[TBL] [Abstract][Full Text] [Related]
11. Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study.
Thenappan T; Stulak JM; Agarwal R; Maltais S; Shah P; Eckman P; Emani S; Katz JN; Gregoric I; Keebler ME; Uriel N; Adler E; Chuang J; Farrar DJ; Sundareswaran KS; John R
J Heart Lung Transplant; 2018 Jan; 37(1):25-32. PubMed ID: 29153636
[TBL] [Abstract][Full Text] [Related]
12. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
13. Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends.
Hurst TE; Xanthopoulos A; Ehrlinger J; Rajeswaran J; Pande A; Thuita L; Smedira NG; Moazami N; Blackstone EH; Starling RC
ESC Heart Fail; 2019 Oct; 6(5):1005-1014. PubMed ID: 31318170
[TBL] [Abstract][Full Text] [Related]
14. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
[TBL] [Abstract][Full Text] [Related]
15. Current risks of HeartMate II pump thrombosis: Non-parametric analysis of Interagency Registry for Mechanically Assisted Circulatory Support data.
Smedira NG; Blackstone EH; Ehrlinger J; Thuita L; Pierce CD; Moazami N; Starling RC
J Heart Lung Transplant; 2015 Dec; 34(12):1527-34. PubMed ID: 26681122
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Pre-Explant Lactate Dehydrogenase Concentrations and Findings During Post-Explant Pump Analysis of the HeartMate II Left Ventricular Assist Device.
Sood V; Alam O; Tchantchaleishvili V; Pagani FD; Aaronson KD; Haft J; Joyce DL; Joyce LD; Daly RC; Maltais S; Stulak JM
Ann Thorac Surg; 2017 Apr; 103(4):1207-1213. PubMed ID: 27743635
[TBL] [Abstract][Full Text] [Related]
17. Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device.
Klodell CT; Massey HT; Adamson RM; Dean DA; Horstmanshof DA; Ransom JM; Salerno CT; Cowger JA; Aranda JM; Chen L; Long JW; Dembitsky W
J Card Surg; 2015 Oct; 30(10):775-80. PubMed ID: 26283153
[TBL] [Abstract][Full Text] [Related]
18. Incidence of increases in pump power use and associated clinical outcomes with an axial continuous-flow ventricular assist device.
Steffen RJ; Soltesz EG; Miracle K; Lee S; Mountis M; Moazami N
J Heart Lung Transplant; 2014 Jan; 33(1):105-6. PubMed ID: 24418736
[No Abstract] [Full Text] [Related]
19. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
[TBL] [Abstract][Full Text] [Related]
20. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
